Clinical Trials on Sternal Infection in Australia

Total 1889 results

Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
The University of Queensland
University of California, Los Angeles; Monash University; University of Sydney; Griffith University and other collaborators

Active, not recruiting

Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII) (GRANDII)

Gonorrhea | Antimicrobial Stewardship | Drug Resistance, Microbial

Australia
Huahui Health

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers

Hepatitis B

Australia
FixHepC

Unknown

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods (REDEMPTION)

Hepatitis C

Australia
Abbott

Completed

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

Australia
MedImmune LLC

Completed

Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

Respiratory Syncytial Virus Infections | Chronic Lung Disease and <= 24 Months of Age or | Premature With Gestational Age <=35 Weeks and <=6 Months of Age

Australia, Chile, New Zealand
GlaxoSmithKline

Completed

Phase I Study of Colistin Methanesulfonate Sodium

Infections, Pseudomonas

Australia
Vir Biotechnology, Inc.

Completed

Study of VIR-2482 in Healthy Volunteers

Influenza A

Australia
Immune Targeting Systems Ltd
INCResearch Australia Pty Limited

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)

Influenza A

Australia
Institut National de la Santé Et de la Recherche...
Medical University of Vienna

Completed

Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue (AB-Direct)

Gonorrhea | Infection, Bacterial

Austria, France
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

SPL7013 Gel - Male Tolerance Study

Human Immunodeficiency Virus (HIV)

Australia
University of Melbourne
Melbourne Health; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Effect of High Dose Vitamin D Supplementation on HIV Latency (VIVA)

Human Immunodeficiency Virus

Australia
Kirby Institute
Flinders University; South Australian Health and Medical Research Institute

Recruiting

Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination (SCALE-C)

Liver Diseases | Digestive System Diseases | RNA Virus Infections | Hepatitis | Hepatitis, Viral, Human | Hepatitis C

Australia
Kirby Institute
Government of Western Australia, Department of Health; Western Australia AIDS...

Completed

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial (PrEPIT-WA)

HIV Prevention

Australia
Murdoch Childrens Research Institute
Royal Children's Hospital; Mercy Hospital for Women, Australia

Completed

A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study (ELVIS)

Innate Immune Response

Australia
The University of Western Australia
Royal Perth Hospital; Fiona Stanley Hospital; Perth Urology Clinic

Completed

Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury

Spinal Cord Injuries

Australia
Queensland Institute of Medical Research
National Health and Medical Research Council, Australia; Australian Department... and other collaborators

Completed

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas (EPL)

Lymphoma

Australia
Intravacc B.V.
Novotech (Australia) Pty Limited

Completed

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers (ITV2002)

COVID-19

Australia
The University of Queensland
Metro North Hospital and Health Service; Pathology Queensland

Recruiting

T2 and SeptiCyte RAPID Duration Project

Bacteremia

Australia
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers

Malaria, Falciparum

Australia
Ellume Pty Ltd

Completed

Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

Influenza

Australia
Viralytics

Completed

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

Stage IV Melanoma

Australia
Arbutus Biopharma Corporation

Completed

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

Hepatitis B, Chronic

Australia, New Zealand
Dr. Reddy's Laboratories Limited

Completed

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Head Lice Infestation

Australia
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Encephalitis, Tick-Borne

Germany, Austria, Poland
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

HIV Infections | HSV-2 Genital Herpes

Australia
RVAC Medicines (US), Inc.

Terminated

Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273

COVID-19 | Infectious Disease

Australia
Medical University of Graz
University of Rostock

Completed

Microbiome and Volatile Organic Compounds in Patients With CDH (CDHVOCS)

Congenital Diaphragmatic Hernia

Austria
Opal Rheumatology Ltd.
Merck Sharp & Dohme LLC

Unknown

Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Australia
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
The Prince Charles Hospital
Cell and Tissue Therapies Western Australia

Completed

A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation (MSC in OB)

Bronchiolitis Obliterans | Lung Transplantation

Australia
Kirby Institute

Recruiting

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs (TOPIC)

Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Novavax

Completed

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Respiratory Syncytial Viruses

Australia
Medical University of Graz

Recruiting

Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders

Psychological Distress | Corona Virus Infection | Psychiatric Disorder

Austria
Medical University of Vienna
Valneva Austria GmbH

Unknown

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

Japanese Encephalitis Vaccine

Austria
Merck KGaA, Darmstadt, Germany

Completed

First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants

Healthy

Australia
Kirby Institute

Recruiting

Real World Assessment of People Living With Chronic Hepatitis B in Australia (REACH-B)

Hepatitis B

Australia
Qualizyme Diagnostics GmbH & Co KG

Completed

The Use of Biochemical Analyzes to Monitor the Development of Wounds (NPWW)

Wound Infection | Wound | Wound Contamination | Negative Pressure Wound Therapy | Biomarker | Diagnostic Techniques and Procedures

Austria
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Meningitis, Meningococcal

Australia
GlaxoSmithKline

Completed

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

Toxoplasmosis

Australia
Medical University of Vienna

Completed

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Tick-borne Encephalitis

Austria
The University of Western Australia
Osteology Foundation

Completed

Surgical Treatment of Peri-implantitis (STP)

Peri-Implantitis

Australia
Kirby Institute

Completed

Hepatitis B Acceptability and Vaccination Incentive Trial (HAVIT)

Hepatitis B

Australia
Bayside Health
National Health and Medical Research Council, Australia

Completed

A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients

Invasive Aspergillosis

Australia
CanSino Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis

Australia
Medical University of Graz

Recruiting

Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates (pFTOE)

Preterm Birth | Neonatal Infection

Austria
Melbourne Health
Peter MacCallum Cancer Centre, Australia; Western Sydney Local Health District and other collaborators

Enrolling by invitation

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient (CReSCT)

Cytomegalovirus Infections | Immune Suppression | Haematological Malignancy | Organ or Tissue Transplant; Complications

Australia
Medical University of Vienna

Completed

Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy

Pneumonia, Ventilator-Associated

Austria
Macfarlane Burnet Institute for Medical Research...
Gilead Sciences

Completed

Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study

Hepatitis C

Australia
Kirby Institute

Completed

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)

Hepatitis C

Australia, New Zealand

Clinical Trials on Sternal Infection in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations